首页 /药靶模型 /免疫治疗 /Co-Inhibitory /B2M-associated HLA-G/aAPC Cell

B2M-associated HLA-G/aAPC Cell

CBP74189

询 价
索取Protocol
产品描述
产品数据库
I. Background
      HLA-G基因是一个功能性的非经典I类HLA分子,具有经典样HLA抗原结构,位于染色体6p21.3的MHC区,然而与经典HLA-I类分子相比,HLA-G具有更少的多态性和更有限的组织分布。β2-微球蛋白(B2M)是细胞膜上组织相容性复合体(MHC,一组编码人类白细胞表面抗原HLA基因群的通称)轻链结构的组成部分,在正常细胞新陈代谢过程中与MHC分离后释放入血。β2-微球蛋白(B2M)分布于几乎所有有核细胞(尤其在淋巴细胞和单核细胞存在丰富)和生物体液,包括血清、尿液和(关节)滑液。
 
II. Introduction
Host Cell: N/A
Stability: 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.)
Freeze Medium: 90% FBS+10% DMSO
Culture Medium: F12K+10%FBS+3μg/ml puromycin+600μg/ml+5μg/ml blasticidin
Mycoplasma Testing: Negative
Storage: Liquid nitrogen
Application(s): Functional(Report Gene) Assay
 
 
III. Representative Data

Figure 1. Recombinant B2M-associated HLA-G/aAPC Cell stably expressing B2M.

Figure 2. Recombinant B2M-associated HLA-G/aAPC Cell stably expressing HLA-G.

Figure 3. Dose Response of LILRB1 Blocking Antibody in LILRB1 Effector Reporter Cells (C13) With B2M-associated HLA-G/aAPC Cells (C15).

Figure 4.Dose Response of LILRB2 Blocking Antibody in LILRB2 Effector Reporter Cells (C24) With B2M-associated HLA-G/aAPC Cells(C15).

 

药靶模型联系方式: 华东销售经理:18240630236 全国销售经理:18066071954
诊断标准品联系方式: 华东销售经理:15000320447 华北销售经理:18131625521 华南销售经理:13484295986 华中&西南销售经理:13871580511 全国销售经理:13484295986

扫二维码

立即提交
XML 地图